The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NKTR-214 + nivolumab in first-line advanced/metastatic urothelial carcinoma (mUC): Updated results from PIVOT-02.
 
Arlene O. Siefker-Radtke
Consulting or Advisory Role - AstraZeneca; Bavarian Nordic; BioClin Therapeutics; Bristol-Myers Squibb; Janssen; Lilly; Merck; NCCN; Nektar; Seagen
Speakers' Bureau - Genentech
Research Funding - BioClin Therapeutics; Bristol-Myers Squibb; Janssen; Michael and Sherry Sutton Fund for Urothelial Cancer; Nektar; NIH; Takeda
Patents, Royalties, Other Intellectual Property - Methods of characterizing and treating molecular subsets of muscle-invasive bladder cancer.
 
Mayer N. Fishman
Consulting or Advisory Role - Novartis; Pfizer; Pfizer
Speakers' Bureau - Exelixis; Ipsen; Medivation
Research Funding - Acceleron Pharma (Inst); Alkermes (Inst); Argos Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); Merck (Inst); Merck (Inst); Nektar (Inst); Pfizer (Inst); Prometheus (Inst)
 
Arjun Vasant Balar
Honoraria - AstraZeneca/MedImmune; Genentech/Roche; Merck
Consulting or Advisory Role - AstraZeneca/MedImmune; Cerulean Pharma; Genentech/Roche; Incyte; Merck; Pfizer/EMD Serono; Seattle Genetics/Astellas
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Merck (Inst); Seagen
 
Giovanni Grignani
No Relationships to Disclose
 
Adi Diab
Consulting or Advisory Role - Celgene; CureVac; Nektar
Research Funding - Celgene (Inst); Idera (Inst); Nektar (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Nektar
 
Jianjun Gao
Travel, Accommodations, Expenses - AstraZeneca
 
Mary Ann Tagliaferri
Employment - Nektar
Leadership - Nektar
Stock and Other Ownership Interests - Nektar
Patents, Royalties, Other Intellectual Property - Nektar
Travel, Accommodations, Expenses - Bluebird Bio (I); Nektar
 
Alison L. Hannah
Leadership - NeoGenomics Laboratories
Stock and Other Ownership Interests - NeoGenomics Laboratories
Consulting or Advisory Role - Basilea; Jazz Pharmaceuticals; Medivation; Nektar
 
Erin E. Karski
Employment - Genentech; Nektar
Stock and Other Ownership Interests - Genentech; Nektar
 
Jonathan Zalevsky
No Relationships to Disclose
 
Ute Hoch
Other Relationship - Nektar
 
Ahsan NAQI Rizwan
Employment - Nektar
Stock and Other Ownership Interests - Nektar
 
Mehmet Asim Bilen
Consulting or Advisory Role - Exelixis; Nektar; Sanofi
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Nektar (Inst); Peleton (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst)